Co-induction of Apaf-1 and caspase-9 enhanced the degree of p53-mediated apoptosis, suggesting that co-induction of p53, Apaf-1 and caspase-9 can be used as a modality for the gene therapy of cancers. This evidence concerns the gene CASP9 and cancer.